Anti-diabetic Medication (Patient Information Leaflets):
[These links open in a separate window with information provided by other websites]
Oral Medication:
- Biguanides:
- Metformin: Tablets (500 mg), Tablets (850 mg)
- Metformin SR (slow release): Tablets
- Sulfonylureas:
- Meglitinides (Prandial glucose regulators):
- Repaglinide: Tablets
- Thiazolidinedione (Glitazone):
- Pioglitazone: Tablets
- DDP-4 Inhibitors (Gliptins):
- Linagliptin (Trajenta): Tablets
- SGLT-2 Inhibitors (Flozins):
- Canagliflozin (Invokana): Tablets
- Dapagliflozin (Forxiga): Tablets
- Empagliflozin (Jardiance): Tablets
- Appropriate use of SGLT2 inhibitors
- SGLT-2 Inhibitors (Flozins) with Metformin:
- SGLT-2 Inhibitors (Flozins) with DDP-4 Inhibitors:
- Dapagliflozin and Saxagliptin (Qtern): Tablets
Injectables — Anti-diabetic medication with weight reduction properties:
- GLP-1 Analogues:
- Liraglutide (Victoza): Pre-filled pen
- Dulaglutide (Trulicity): Instruction manuals (0.75 mg and 1.5 mg pre-filled pens), instructional video (US website) and information leaflet
Injectables — Insulins:
- Insulin explained
- Rapid-acting Insulins:
- Fiasp: Pre-filled pen (FlexTouch), Cartridge, Vial
- NovoRapid: Pre-filled pen (FlexPen), Pre-filled pen (FlexTouch), Cartridge
- Humalog (U-100)*: Pre-filled pen (Kwikpen) and its User Manual, Cartridge
- Humalog (U-200)*: Pre-filled pen (Kwikpen) and its User Manual
- Long-acting Insulins:
- Detemir (Levemir): Pre-filled pen (FlexPen), Cartridge
- Glargine (Lantus; U-100): Pre-filled pen (SoloStar), Cartridge
- Glargine (Toujeo; U-300)*: Pre-filled pen (SoloStar)
- Degludec (Tresiba U-100)*: Pre-filled pen (FlexTouch), Cartridge
- Degludec (Tresiba U-200)*: Pre-filled pen (FlexTouch)
- Mix Insulins:
- NovoMix 30: Pre-filled pen (FlexPen), Cartridge
- Humalog Mix 50: Pre-filled pen (Kwikpen), Cartridge
- Intermediate-acting Insulins:
- Insulatard: Cartridge
- Humulin I: Pre-filled pen (Kwikpen) and its User Manual, Cartridge
*In the UK, insulins are generally of U-100 concentration (i.e., 100 units of insulin per milli-litre [mL] of solution). There are exceptions to this and in those instances the concentration of the insulin is higher and special markings highlight this in order to avoid confusion and drug errors. These exceptions include the insulin concentrations of U-200 (with 200 units of insulin per milli-litre [mL] of solution) and U-300 (with 300 units of insulin per milli-litre [mL] of solution).
Weight reduction (Anti-obesity) Injections (Patient Information Leaflets):
- Saxenda (Liraglutide): Injection (information leaflet) and instructional video [US website]
Weight reduction (Anti-obesity) Oral Medications (Patient Information Leaflets):
- Xenical (Orlistat): Capsules
Miscellaneous Medications and Treatments (Patient Information Leaflets):
- To correct a ‘hypo’ (low sugar level):
- GlucaGen Hypokit: Injection
- Islet Transplant
- Insulin Pumps
- Cholesterol control:
- To help with painful diabetic peripheral neuropathy: